To include your compound in the COVID-19 Resource Center, submit it here.

Midthun to allow discussion of future Avastin studies at hearing

CBER Director Karen Midthun indicated she will allow Genentech Inc. to present information

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE